ANTARA® (fenofibrate)

DRUG2 trials

Sponsors

Ranbaxy Laboratories Limited

Conditions

Healthy

Unknown Phase

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions

CompletedNCT02306902

Ranbaxy Laboratories LimitedHealthy

Start: 2009-10-31End: 2010-04-30Updated: 2014-12-03

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions

CompletedNCT02306889

Ranbaxy Laboratories LimitedHealthy

Start: 2010-01-31End: 2010-04-30Updated: 2014-12-03